D. Boral ARC Acquisition I Corp.

D. Boral ARC Acquisition I Corp. (BCARU, BCAR, BCARW): Charting Its Course to a Business Combination

This summary offers an investor-focused overview of D. Boral ARC Acquisition I Corp.'s performance and strategic developments. It draws from their 10-K annual report for the year ended December 31, 2025, and subsequent key announcements, providing insight into the company's journey and future plans.

Business Overview D. Boral ARC Acquisition I Corp. (the "Company") operates as a Special Purpose Acquisition Company (SPAC), commonly known as a "blank check company." Formed in March 2025, its sole mission is to identify, acquire, and merge with a private operating company, ultimately bringing it public. The Company's strategy leverages the extensive network and mergers and acquisitions (M&A) expertise of its management team and sponsor, MFH 1, LLC, to pinpoint a promising business. The Company prioritizes identifying businesses with strong growth potential that can benefit from its team's experience in strategic acquisitions, deal-making, and integration. The Company must complete a business combination by August 1, 2027, which is 24 months from its Initial Public Offering (IPO).

Financial Performance (Year Ended December 31, 2025) As a SPAC, D. Boral ARC Acquisition I Corp. does not generate traditional operating revenue. Instead, its financial performance reflects its capital-raising success and the diligent management of its trust account.

• Initial Public Offering (IPO): The Company successfully completed its IPO on August 1, 2025, selling 25,000,000 units at $10.00 each and raising $250,000,000. Furthermore, the underwriters exercised their over-allotment option, purchasing an additional 3,000,000 units. This brought the total gross IPO proceeds to $280,000,000.
• Private Placement: Alongside the IPO, the sponsor, MFH 1, LLC, purchased 200,000 private placement warrants for $2,000,000. Each warrant allows the holder to purchase one Class A common share at $11.50.
• Trust Account: The Company deposited a substantial portion of the IPO proceeds—$280,000,000—into a trust account. This account securely holds funds, invested in U.S. government securities or money market funds, solely to finance a business combination or return capital to shareholders. By December 31, 2025, interest earnings had boosted the trust account balance to approximately $284,776,628.
• Operating Capital & Expenses: Outside the trust account, the Company held approximately $1.5 million in cash to cover its operating expenses. For the year ended December 31, 2025, the Company reported a net loss of approximately $1.2 million. This loss primarily stemmed from administrative and operating costs related to its public status and the ongoing search for an acquisition target.

Management's Discussion and Analysis (MD&A) Highlights For the year ended December 31, 2025, as a newly public Special Purpose Acquisition Company (SPAC), D. Boral ARC Acquisition I Corp. primarily focused its operations on activities related to its Initial Public Offering and the search for a suitable business combination target.

• Results of Operations: The Company generated no operating revenues. Its primary activities led to administrative and operating expenses. From its inception in March 2025 through December 31, 2025, the Company reported a net loss of approximately $1.2 million. This loss stemmed primarily from general and administrative expenses, professional fees (legal, accounting, audit) associated with being a public company, and costs for identifying and evaluating potential acquisition targets. Interest income of approximately $4.7 million earned on the trust account partially offset these expenses, though it is not considered operating revenue.
• Liquidity and Capital Resources (Financial Health): The Company primarily derives its liquidity from IPO and private placement proceeds held outside the trust account. As of December 31, 2025, the Company held approximately $1.5 million in cash outside the trust account, earmarked to cover operating expenses and business combination search costs. The vast majority of IPO proceeds—$280,000,000, plus earned interest, totaling approximately $284,776,628—resides in a trust account. These funds are designated for completing a business combination or for redemptions to public shareholders. The Company believes its current cash resources outside the trust account are sufficient to meet its working capital needs for at least the next 12 months, whether it completes a business combination or liquidates. The Company currently carries no significant debt obligations.
• Off-Balance Sheet Arrangements: The Company has no off-balance sheet arrangements that have, or are reasonably likely to have, a current or future material effect on its financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources.

Future Outlook Looking ahead, the proposed business combination with Exascale Labs Inc. stands as the Company's most critical future event.

• Key Developments & Performance Milestones (2025): The year 2025 proved pivotal for D. Boral ARC Acquisition I Corp.:
  • Successful IPO & Public Listing: The Company's units, Class A common stock, and warrants began trading on the Nasdaq stock market under the symbols BCARU, BCAR, and BCARW, respectively.
  • Target Identification & Merger Agreement: A significant achievement was identifying Exascale Labs Inc. as a suitable target company. This led to the announcement of a definitive merger agreement on January 11, 2026—a key development shortly after the 10-K's reporting period.
• The Proposed Merger with Exascale Labs Inc.:
  • Exascale Labs Inc.: Subsequent filings reveal Exascale Labs Inc. is a rapidly growing technology company specializing in advanced AI-driven data analytics solutions for enterprise clients.
  • Transaction Details: The deal values Exascale Labs Inc. at $500,000,000. Upon closing, D. Boral ARC Acquisition I Corp. will reincorporate in Delaware as "PubCo" (the new public entity), and Exascale Labs will merge into it. Exascale's existing shareholders will receive 50,000,000 new shares of the combined company, valued at $10.00 per share, comprising a mix of Class A (one vote per share) and Class B (twenty votes per share) common stock.
  • Expected Timeline & Conditions: The merger requires approval from both companies' shareholders, regulatory bodies, and other standard closing conditions. The Company anticipates the merger to close in the second half of 2026.

Competitive Position The Company's competitive edge stems from its management team's deep experience in financial markets, mergers and acquisitions (M&A), and identifying high-growth companies. They plan to leverage this expertise not only to complete the merger but also to support Exascale Labs Inc.'s transition to a public company and its subsequent growth.

Risk Factors Investing in a SPAC, particularly one pursuing a business combination, involves specific risks:

• Merger Completion Risk: The proposed merger with Exascale Labs Inc. may not be completed by the August 1, 2027, deadline, or at all. Failure to complete a merger would lead to the SPAC's liquidation and a return of trust account funds to public shareholders, likely at or near the initial $10.00 per share, but without any potential for growth.
• Shareholder Redemptions: A significant number of public shareholders may choose to redeem their shares for cash from the trust account. Such redemptions could reduce the capital available to the combined company, potentially impacting its post-merger growth plans.
• Risks Related to Exascale Labs Inc.: Investors will face the business, financial, and operational risks inherent to Exascale Labs Inc., including its ability to execute its growth strategy, competitive pressures, and market acceptance of its technology.
• Dilution: Issuing shares to Exascale shareholders, exercising warrants (including those held by the sponsor), and converting founder shares could significantly dilute public shareholders' ownership.
• Regulatory Scrutiny: Increasing regulatory scrutiny of the SPAC market could impact the merger process or the combined company's future operations.
• Dependence on Management: The success of the SPAC and the combined company heavily depends on its management team's and sponsor's expertise and continued involvement.
• Regulatory Considerations: The Company carefully manages its trust account and operations to avoid classification as an "investment company" under the Investment Company Act of 1940, which would impose significant regulatory burdens. Evolving regulatory guidance from the SEC for the broader SPAC market could also impact future operations.